Cite
HARVARD Citation
Oh, S. et al. (n.d.). A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial. Leukemia & lymphoma. 57 (6), pp. 1406-1412. [Online].